Literature DB >> 18068039

Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging.

Masayoshi Sarai1, Dagmar Hartung, Artiom Petrov, Jun Zhou, Navneet Narula, Leo Hofstra, Frank Kolodgie, Satoshi Isobe, Shinichiro Fujimoto, Jean-Luc Vanderheyden, Renu Virmani, Chris Reutelingsperger, Nathan D Wong, Sudhir Gupta, Jagat Narula.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate the role of caspase inhibitors on acute resolution of apoptosis in atherosclerotic lesions as evaluated by imaging with annexin A5.
BACKGROUND: Extensive apoptosis of macrophages has been reported at the site of plaque rupture in patients dying of acute coronary syndrome.
METHODS: Of 31 New Zealand White atherosclerotic rabbits, 6 received broad caspase, 3 received caspase-1, 3 received caspase-3, 3 received caspase-8, and 4 received caspase-9 inhibitors; 12 animals did not receive any caspase inhibitors (treatment control group). Six unmanipulated rabbits were used for comparison (disease control group). Technetium-99m-labeled annexin A5 was used for imaging atherosclerotic lesions; 6 of the 12 uninhibited atherosclerotic rabbits received (99m)Tc-labeled mutant annexin A5 (radiotracer control group). Gamma images were obtained, and quantitative radiotracer uptake was compared with pathologic findings.
RESULTS: Atherosclerotic lesions were best visible in untreated atherosclerotic rabbits. Quantitative annexin uptake, defined as the percent of injected dose per g of abdominal aorta tissue, was significantly higher in untreated atherosclerotic animals (mean +/- SD = 0.0515 +/- 0.0099) compared with the normal rabbits (0.0065 +/- 0.0008; p < 0.0001) or atherosclerotic rabbits receiving mutant annexin (0.014 +/- 0.0024; p < 0.0001). Among all caspase inhibitor-treated rabbits, uptake was 39% lower (0.0314 +/- 0.0151) than in untreated atherosclerotic animals (p < 0.01). Uptake was also significantly lower in rabbits receiving broad caspase (0.0206 +/- 0.0058; p < 0.0001) or caspase-1, -3, or -9 (0.0272 +/- 0.0088, p < 0.01; 0.0286 +/- 0.0095, p < 0.01; 0.0300 +/- 0.0021, p < 0.01, respectively) inhibitors. Caspase-8 inhibitor did not affect apoptosis (0.0618 +/- 0.0047; p = NS). Upon histologic characterization, a substantial decrease in macrophage apoptosis was observed in caspase-inhibited animals.
CONCLUSIONS: Molecular imaging, using radiolabeled annexin A5, allows the detection of acute resolution of apoptosis as a result of caspase inhibition in experimental atherosclerosis. If proven clinically, this may allow development of novel intervention strategies in acute vascular events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18068039     DOI: 10.1016/j.jacc.2007.08.044

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

1.  Molecular imaging of atherosclerotic plaques targeted to oxidized LDL receptor LOX-1 by SPECT/CT and magnetic resonance.

Authors:  Dayuan Li; Amit R Patel; Alexander L Klibanov; Christopher M Kramer; Mirta Ruiz; Bum-Yong Kang; Jawahar L Mehta; George A Beller; David K Glover; Craig H Meyer
Journal:  Circ Cardiovasc Imaging       Date:  2010-05-04       Impact factor: 7.792

2.  Cardioprotection by minocycline in a rabbit model of ischemia/reperfusion injury: Detection of cell death by in vivo 111In-GSAO SPECT.

Authors:  Takayoshi Yamaki; Hans J de Haas; Nobuhiro Tahara; Artiom Petrov; Dilbahar Mohar; Nezam Haider; Jun Zhou; Atsuko Tahara; Yasuchika Takeishi; Hendrikus H Boersma; Tiziano Scarabelli; Annapoorna Kini; H William Strauss; Jagat Narula
Journal:  J Nucl Cardiol       Date:  2017-08-24       Impact factor: 5.952

Review 3.  Imaging atherosclerosis and vulnerable plaque.

Authors:  Mehran M Sadeghi; David K Glover; Gregory M Lanza; Zahi A Fayad; Lynne L Johnson
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

Review 4.  Endothelial dysfunction: the role of sterol regulatory element-binding protein-induced NOD-like receptor family pyrin domain-containing protein 3 inflammasome in atherosclerosis.

Authors:  Zhen Chen; Marcy Martin; Zhao Li; John Y-J Shyy
Journal:  Curr Opin Lipidol       Date:  2014-10       Impact factor: 4.776

5.  Radiolabelled probes for imaging of atherosclerotic plaques.

Authors:  Takashi Temma; Hideo Saji
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-10-15

6.  Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis.

Authors:  Nezam Haider; Dagmar Hartung; Shinichiro Fujimoto; Artiom Petrov; Frank D Kolodgie; Renu Virmani; Satoru Ohshima; Han Liu; Jun Zhou; Ai Fujimoto; Atsuko Tahara; Leo Hofstra; Navneet Narula; Chris Reutelingsperger; Jagat Narula
Journal:  J Nucl Cardiol       Date:  2009-08-07       Impact factor: 5.952

7.  Will molecular optical imaging have clinically important roles in stroke management, and how?

Authors:  Dong Kun Lee; Matthias Nahrendorf; Dawid Schellingerhout; Dong-Eog Kim
Journal:  J Clin Neurol       Date:  2010-03-26       Impact factor: 3.077

Review 8.  The year in molecular imaging.

Authors:  Eric A Osborn; Farouc A Jaffer
Journal:  JACC Cardiovasc Imaging       Date:  2009-01

Review 9.  Pre-clinical and clinical evaluation of nuclear tracers for the molecular imaging of vulnerable atherosclerosis: an overview.

Authors:  L M Riou; A Broisat; J Dimastromatteo; G Pons; D Fagret; C Ghezzi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

10.  Molecular MRI detects low levels of cardiomyocyte apoptosis in a transgenic model of chronic heart failure.

Authors:  David E Sosnovik; Matthias Nahrendorf; Peter Panizzi; Takashi Matsui; Elena Aikawa; Guangping Dai; Ling Li; Fred Reynolds; Gerald W Dorn; Ralph Weissleder; Lee Josephson; Anthony Rosenzweig
Journal:  Circ Cardiovasc Imaging       Date:  2009-09-01       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.